The FDA approved the Merck version of its successful infusion Keytruda. The company says that it will be faster and easier, but is able to slow down the adoption of cheaper competitors and increase the costs of billions of dollars.
The FDA approved the Merck version of its successful infusion Keytruda. The company says that it will be faster and easier, but is able to slow down the adoption of cheaper competitors and increase the costs of billions of dollars.